Wachtell and Cravath lead for Pfizer/Mylan merger
Credit: iStock/Gannet77
Pfizer and Mylan have tapped Wachtell Lipton Rosen & Katz and Cravath Swaine & Moore, respectively, to oversee the proposed combination of Pfizer’s Upjohn and generic drugmaker Mylan.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now